Tuberous sclerosis complex (TSC) is a genetic disorder affecting cellular differentiation, proliferation, and migration early in development, resulting in a variety of hamartomatous tumours effecting vital organs.
Prevalance of Tuberous sclerosis is reported to be less than 1 in 10,000 of population. Tuberous sclerosis is listed as a "rare disease" by the Office of Rare Diseases (ORD)
Specific medications may be prescribed for behaviour problems. Intervention programs including special schooling and occupational therapy may benefit individuals with special needs and developmental issues.
Researches are focusing on facilitating the development of a major early invention study. This is likely to be based around the use of an mTOR inhibitor to in early childhood.